Report: Cancer Panorama in France (France): Difference between revisions
No edit summary |
m (Update categories.) |
||
| (9 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
<span style="display:none">forpolicymakers</span> <span style="display:none">francecountry</span> | |||
Go back to [[France]] page | Go back to [[France]] page | ||
'''Primary purpose:''' To provide a concise overview of the latest essential data on major cancers in France, including incidence, mortality, survival, etc., as well as preventive and treatment actions that can be taken before, during, and after the disease. | '''Primary purpose:''' To provide a concise overview of the latest essential data on major cancers in France, including incidence, mortality, survival, etc., as well as preventive and treatment actions that can be taken before, during, and after the disease. | ||
'''Sponsor, manager or home institution:''' Institut National du Cancer. | '''Sponsor, manager or home institution:''' [[dataOwner::Institut National du Cancer]]. | ||
'''Type of information:''' | '''Type of information:''' [[availableVariable::cancer incidence]]; New cases of cancer; Cancer annual evolution; [[availableVariable::numbers of deaths]] due cancer; [[availableVariable::cancer survival]] rate; [[availableVariable::cancer prevalence]]; [[availableVariable::risk of cancer|Risk factors]]; Participation in organized cancer [[availableVariable::screening]]s; Number of cancers detected by screenings; [[availableVariable::number of patients]] hospitalizations in connection with the [[availableVariable::diagnosis]], [[availableVariable::medical procedures|treatment]] or monitoring of cancer. [https://www.e-cancer.fr/content/download/336357/4805630/file/01_brochure_Panorama-2022-V2-@.pdf Click here to learn more]. | ||
'''Data level:''' | '''Data level:''' [[dataLevel::national level]]. | ||
'''Cancer areas of interest:''' [[hasCancerType::C30-C39: Lung/chest cancers]], [[hasCancerType::C50: Breast cancer]], [[C60-C63: Male genitalia cancer]], [[hasCancerType::C15-C26: Digestive system cancers]], [[hasCancerType::C51-C58: Female genitalia cancer]], [[hasCancerType::C43-C44: Skin cancers/melanoma]]. [https://www.e-cancer.fr/content/download/336357/4805630/file/01_brochure_Panorama-2022-V2-@.pdf Click here to learn more]. | '''Cancer areas of interest:''' [[hasCancerType::C30-C39: Lung/chest cancers]], [[hasCancerType::C50: Breast cancer]], [[hasCancerType::C60-C63: Male genitalia cancer]], [[hasCancerType::C15-C26: Digestive system cancers]], [[hasCancerType::C51-C58: Female genitalia cancer]], [[hasCancerType::C43-C44: Skin cancers/melanoma]]. [https://www.e-cancer.fr/content/download/336357/4805630/file/01_brochure_Panorama-2022-V2-@.pdf Click here to learn more]. | ||
'''Access to information:''' | '''Access to information:''' [https://www.e-cancer.fr/Expertises-et-publications/Catalogue-des-publications/Panorama-des-cancers-en-France-Edition-2022 Click here to access]. | ||
<span style="display:none">Lung</span> | |||
<span style="display:none">Trachea</span> | |||
<span style="display:none">Bronchi</span> | |||
<span style="display:none">Pleura</span> | |||
<span style="display:none">Mediastinum</span> | |||
<span style="display:none">Lobular</span> | |||
<span style="display:none">Breast</span> | |||
<span style="display:none">Nipple</span> | |||
<span style="display:none">Areola</span> | |||
<span style="display:none">Ductal</span> | |||
<span style="display:none">Prostate</span> | |||
<span style="display:none">Testicles</span> | |||
<span style="display:none">Penis</span> | |||
<span style="display:none">Esophagus</span> | |||
<span style="display:none">Stomach</span> | |||
<span style="display:none">Small intestine</span> | |||
<span style="display:none">Large intestine</span> | |||
<span style="display:none">Rectum</span> | |||
<span style="display:none">Anus</span> | |||
<span style="display:none">Liver</span> | |||
<span style="display:none">Gallbladder</span> | |||
<span style="display:none">Bile ducts</span> | |||
<span style="display:none">Pancreas</span> | |||
<span style="display:none">Colon</span> | |||
<span style="display:none">Vulva</span> | |||
<span style="display:none">Vagina</span> | |||
<span style="display:none">Cervix</span> | |||
<span style="display:none">Uterus</span> | |||
<span style="display:none">Ovary</span> | |||
<span style="display:none">Fallopian tubes</span> | |||
<span style="display:none">Endometrium</span> | |||
<span style="display:none">Skin</span> | |||
<span style="display:none">Melanoma</span> | |||
<span style="display:none">Scalp</span> | |||
<span style="display:none">Lips</span> | |||
<span style="display:none">Hands</span> | |||
<span style="display:none">Feet</span> | |||
<span style="display:none">dataOwner::Institut National du Cancer</span> | |||
<span style="display:none">availableVariable::cancer incidence</span> | |||
<span style="display:none">availableVariable::numbers of deaths</span> | |||
<span style="display:none">availableVariable::cancer survival</span> | |||
<span style="display:none">availableVariable::cancer prevalence</span> | |||
<span style="display:none">availableVariable::risk of cancer|Risk factors</span> | |||
<span style="display:none">availableVariable::screening</span> | |||
<span style="display:none">availableVariable::number of patients</span> | |||
<span style="display:none">availableVariable::diagnosis</span> | |||
<span style="display:none">availableVariable::medical procedures|treatment</span> | |||
<span style="display:none">dataLevel::national level</span> | |||
<span style="display:none">hasCancerType::C51-C58: Female genitalia cancer</span> | |||
<span style="display:none">isReport</span> | |||
<span style="display:none">hasCancerType::C30-C39: Lung/chest cancers</span> | |||
<span style="display:none">hasCancerType::C50: Breast cancer</span> | |||
<span style="display:none">hasCancerType::C60-C63: Male genitalia cancer</span> | |||
<span style="display:none">hasCancerType::C15-C26: Digestive system cancers</span> | |||
<span style="display:none">hasCancerType::C43-C44: Skin cancers/melanoma</span> | |||
<span style="display:none">hasCancerType::C00-D48: All neoplasms</span> | |||
<span style="display:none">hasCancerType::C00-C97: All cancer types</span> | |||
<span style="display:none">Esophageal</span> | |||
<span style="display:none">Gastric</span> | |||
<span style="display:none">Intestinal</span> | |||
<span style="display:none">Bowel</span> | |||
<span style="display:none">Colorectal</span> | |||
<span style="display:none">Appendix</span> | |||
<span style="display:none">Appendiceal</span> | |||
<span style="display:none">Duodenum</span> | |||
<span style="display:none">Jejunum</span> | |||
<span style="display:none">Ileum</span> | |||
<span style="display:none">Anal</span> | |||
<span style="display:none">Perianal</span> | |||
<span style="display:none">Hepatic</span> | |||
<span style="display:none">Biliary</span> | |||
<span style="display:none">Hepatobiliary</span> | |||
<span style="display:none">Cutaneous</span> | |||
<span style="display:none">Dermal</span> | |||
<span style="display:none">Epidermal</span> | |||
<span style="display:none">Axilla</span> | |||
<span style="display:none">Axillary</span> | |||
<span style="display:none">Mammary</span> | |||
<span style="display:none">Prostatic</span> | |||
<span style="display:none">Testicular</span> | |||
<span style="display:none">Penile</span> | |||
Latest revision as of 12:09, 14 December 2025
Go back to France page
Primary purpose: To provide a concise overview of the latest essential data on major cancers in France, including incidence, mortality, survival, etc., as well as preventive and treatment actions that can be taken before, during, and after the disease.
Sponsor, manager or home institution: Institut National du Cancer.
Type of information: cancer incidence; New cases of cancer; Cancer annual evolution; numbers of deaths due cancer; cancer survival rate; cancer prevalence; Risk factors; Participation in organized cancer screenings; Number of cancers detected by screenings; number of patients hospitalizations in connection with the diagnosis, treatment or monitoring of cancer. Click here to learn more.
Data level: national level.
Cancer areas of interest: C30-C39: Lung/chest cancers, C50: Breast cancer, C60-C63: Male genitalia cancer, C15-C26: Digestive system cancers, C51-C58: Female genitalia cancer, C43-C44: Skin cancers/melanoma. Click here to learn more.
Access to information: Click here to access.